BioSenic S.A. (EBR:BIOS)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.0020
0.00 (0.00%)
May 26, 2026, 10:35 AM CET

BioSenic Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
67.080.340.121.850.76
Cash & Short-Term Investments
67.080.340.121.850.76
Cash Growth
19441.47%193.39%-93.66%143.22%-94.82%
Accounts Receivable
9.351.011.322.490.36
Other Receivables
676.580.72---
Total Trade Receivables
685.931.731.322.490.36
Other Current Assets
13.340.240.410.290
Total Current Assets
2,9192.321.854.631.12
Net Property, Plant & Equipment
5.20.010.71.420.01
Other Intangible Assets
338.640.672.9917.29-
Goodwill
--01.80
Long-Term Investments
139.250.140.010.010.03
Other Long-Term Assets
2,15404.014.170
Total Assets
3,3995.489.5629.321.16
Accounts Payable
1,1222.913.872.240.21
Accrued Expenses
-0.05---
Short-Term Debt
--11.828.011.25
Current Portion of Long-Term Debt
2,7873.65---
Other Current Liabilities
124.641.710.150.10.03
Total Current Liabilities
4,0337.0815.8410.351.49
Long-Term Debt
017.816.3415.782.27
Other Long-Term Liabilities
27.522.980.080.070.07
Total Long-Term Liabilities
27.5221.0616.4215.852.34
Total Liabilities
4,06128.1332.2626.23.38
Common Stock
38,40137.46.284.770.66
Additional Paid-in Capital
15,79915.85.724.523.97
Accumulated Other Comprehensive Income
---0.02-0.04-0.08
Retained Earnings
-54,861-77.09-34.89-5.72-7.22
Total Common Shareholders' Equity
-661.42-23.89-22.913.53-2.67
Minority Interest
--0.21-0.4-
Shareholders' Equity
-661.42-23.89-22.713.12-2.67
Total Liabilities & Equity
3,3995.489.5629.321.16
Total Debt
2,78721.4528.1623.793.53
Net Cash (Debt)
-2,719-21.1-28.04-21.95-2.77
Net Cash Per Share
-4.17-0.07-0.20-0.18-0.13
Book Value
-661.42-23.89-22.913.53-2.67
Book Value Per Share
-1.01-0.07-0.170.03-0.13
Tangible Book Value
-1,000-24.56-25.9-15.57-2.67
Tangible Book Value Per Share
-1.53-0.08-0.19-0.13-0.13